Cargando…
Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection
BACKGROUND: The single-nucleotide polymorphism SLC39A6 rs1050631 is strongly implicated in esophageal squamous cell carcinoma, leading us to question whether it may also play a role in gastric adenocarcima (GA). METHODS: We genotyped the SLC39A6 rs1050631 in 512 patients who underwent GA resection....
Autores principales: | Gao, Jian, Ren, Wenjun, Xiao, Chunhong, Wang, Lie, Huang, Qiaojia, Zhang, Zaizhong, Dang, Yuan, Weng, Pengcheng, Wang, Hui, Fang, Xuehong, Zhuang, Minxian, Lin, Liying, Chen, Shaoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839152/ https://www.ncbi.nlm.nih.gov/pubmed/31703635 http://dx.doi.org/10.1186/s12885-019-6222-z |
Ejemplares similares
-
Role of SLC39A6 in the development and progression of liver cancer
por: Wan, Zhen, et al.
Publicado: (2022) -
SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
por: Cui, Xiao-Bin, et al.
Publicado: (2015) -
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021) -
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023) -
Clinical, molecular and glycophenotype insights in SLC39A8-CDG
por: Bonaventura, Eleonora, et al.
Publicado: (2021)